SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-005628
Filing Date
2020-02-21
Accepted
2020-02-20 19:17:04
Documents
3
Period of Report
2020-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20200220.htm 8-K 23523
2 EX-99.1 vtvt-ex991_6.htm EX-99.1 473991
3 GRAPHIC giz1nshuccri000001.jpg GRAPHIC 13695
  Complete submission text file 0001564590-20-005628.txt   517755
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 20637004
SIC: 2834 Pharmaceutical Preparations